Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies

Author： Yap Timothy A   Olmos David   Molife Lulama Rhoda   de Bono Johann S  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.9, 2011-09, pp. : 1293-1304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2899-2911

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer

By Yuen John SP   Macaulay Valentine M  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 589-603

Informa Healthcare

Access to resources Recommend Favorite

Targeting insulin-like growth factor-1 to treat Alzheimer's disease

By Torres-Aleman Ignacio  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1535-1542

Informa Healthcare

Access to resources Recommend Favorite

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 6, 2009-09 ,pp. : 748-760

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin-Like Growth Factor Receptor-1 as an Anti-Cancer Target: Blocking Transformation and Inducing Apoptosis

By  

Current Cancer Drug Targets, Vol. 2, Iss. 3, 2002-09 ,pp. : 191-207

Bentham Science Publishers

Access to resources Recommend Favorite